Contact Us

Our Team

Our leadership team has a shared passion for bringing life-saving solutions to market. They exemplify what it means to be smart innovators in the healthcare space and inspire our work.

Leadership

JASON PESTERFIELD

Jason Pesterfield

President, CEO & Director

Prior to joining Veran in August 2012, Jason had an 18-year career at Stryker, a publicly traded Fortune 500 medical device company with an emphasis on capital sales and operating room equipment. During his tenure, Jason served as Global Vice President and General Manager for the Surgical Navigation division, spearheading Stryker’s fastest-growing capital business in 2006, 2009 and 2010. Jason has a B.A. in Business Administration from the University of Nebraska.

Kirk Jacquay

Kirk Jacquay

Chief Financial Officer and Corporate Secretary

Prior to joining Veran in April of 2016, Kirk had spent 11 years with Stericycle, Inc. where he held a variety of leadership roles.  Stericycle is a Fortune 1000 company that specializes in collecting and disposing regulated substances, such as medical waste, sharps, pharmaceuticals, and hazardous materials, in addition to acting as a service provider for recalled and expired goods.  Most recently, Kirk was Stericycle’s Vice President of Finance of its Environmental Solutions division, where he managed all financial functions and reporting for the business unit.  The Environmental Solutions business was the fastest growing business within Stericycle from 2010 to 2015.  Kirk also led efforts for strategic planning, budgeting, cost accounting, CRM and ERP system implementation, operations, and all aspects of M&A on behalf of Stericycle.  Kirk also held these positions at Stericycle:  Vice President Finance – Communication Solutions; Vice President – Strategic Development; Vice President Operations – Environmental Solutions; and Director – Mergers and Acquisitions.  Prior to joining Stericycle in 2005, Kirk held key leadership positions at several highly-regarded companies including: Eli Lilly, Celadon, Ernst & Young and KPMG.

Troy L. Holsing

Troy L. Holsing

Vice President,  Application Development and Chief Technical Officer

Prior to joining Veran, Troy worked for Surgical Navigation Technologies, Inc. (SNT), Sofamor Danek and Medtronic. At SNT, he helped develop the StealthStation Image Guided Surgery System for Neurosurgery and played a pivotal role in SNT’s sale to Sofamor Danek. At Medtronic, he led development teams for Cranial and Functional Deep Brain Stimulation Image Guidance products and Ultrasound-CT fusion products for intraoperative monitoring of brain shift.

MARK HUNTER

Mark W. Hunter

Executive Vice President, Business Development and Operations

Mark was a co-founder and helped build Surgical Navigation Technologies, Inc. (SNT) from Southern Illinois University in 1993. He and his fellow co-founders moved SNT to Colorado and concurrently obtained an equity investment from Sofamor Danek in 1994. After SNT was acquired by Sofamor Danek and Medtronic, he continued to be a top executive leader until joining Veran in 2007. Mark has 30 issued image guided patents to his name.

Dave Wildermuth

Vice President of Marketing and Clinical Operations

Prior to joining Veran in April 2016, Dave was Chief Marketing Officer for dorsaVi, an Australian manufacturer of biomechanical sensors. Previously, Dave spent twelve years at Medtronic in various leadership positions including heart failure management, market development, remote patient monitoring, and most recently as Senior Marketing Director managing global marketing for the company’s $1B implantable defibrillator business. Before his career in the medical device industry, Dave was an Emmy award winning television reporter. He graduated with a BA from the University of Maryland and has his MBA from the Kellogg Graduate school of Management.

RYAN DENNEY

Ryan Denney

Vice President of Sales

Ryan Denney joined Veran from Olympus Biotech, where he was Vice President of Sales, North America. He brings over 17 years of dynamic sales, marketing and leadership experience to the team, and has held various leadership positions with Stryker Biotech, Artemis Medical, Baxter Healthcare and Tyco. Ryan has a B.S. in Journalism from the University of Missouri-Columbia.

SCOTT WRIGHTSTONE

Scott Wrightstone

Quality and Regulatory Director

Scott brings a wealth of quality and regulatory experience to the Veran team. He served as the Director of Quality Assurance and Regulatory Affairs for Allied Healthcare Products, Inc., managing a $1.5M budget and a 12-member QA/QC/RA team. Prior to his role as Director, he served as a Quality Manager and ISO Coordinator with Allied, managing compliance efforts with ISO, EU MDD and FDA guidelines. With over 12 years of QA/RA experience, he has participated in numerous FDA audits and 510(k) product clearance submissions. Scott has a B.S. in Safety Engineering from Indiana University of Pennsylvania and is a member of the American Society of Quality.

LAURA SPENCER GARTH

Laura Spencer Garth

General Counsel and Director of Human Resources

Laura brings to Veran several years of experience managing a full spectrum of labor, employment, commercial, and human resources-related matters. Laura is a former trial attorney and litigator licensed to practice in Missouri and Illinois. Prior to coming to Veran, Laura worked at Bryan Cave LLP in the Commercial Litigation and Labor and Employment client service groups, where she routinely represented and counseled a wide array of corporate clients in complex business and employment disputes. Laura has also practiced as a plaintiff’s attorney and handled a broad range of state- and nation-wide employment lawsuits and class actions at the state and federal level. She has been selected twice as a Missouri and Kansas Super Lawyers – Rising Star in Employment Litigation (2014 – 2015) and was the recipient of Legal Services of Eastern Missouri’s John R. Essner Award for Young Lawyer of the Year (2014). Laura received her B.A. in Political Science and J.D. from Saint Louis University.

Board of Directors

Prior to joining Veran in August 2012, Jason had an eighteen-year career at Stryker, a publicly traded Fortune 500 medical device company with an emphasis on capital sales and operating room equipment. During his tenure, Jason served as Global Vice President and General Manager for the Surgical Navigation division, spearheading Stryker’s fastest-growing capital business in 2006, 2009, and 2010. Jason has a B.A. in Business Administration from the University of Nebraska.

Prior to joining CONMED, Curt had an illustrious 22-year career at Stryker Corporation, even serving as interim CEO from February to October 2012. During Curt’s tenure, Stryker completed several acquisitions, debt offerings, share buybacks and an enhanced dividend policy. He graduated from the University of Michigan with a B.S. in Aerospace Engineering and obtained an Advanced Management Program Certificate from Harvard Business School.

At River Cities, David works closely with healthcare clients like Veran, TissueTech, OrthAlign and Advanced Practice Strategies. Prior to joining River Cities, David served as an associate with American Financial Group, a registered principal and independent investment adviser and completed extensive training programs with Merrill Lynch and Procter & Gamble. David has a B.S. in Finance from Indiana University’s Kelley School of Business and received his M.B.A. with a concentration in Finance from Xavier University’s Williams College of Business.

Gregory R. Johnson, Ph.D. has served as a Director for Veran since April 2008. Dr. Johnson co-founded Prolog in 2000 following a thirteen-year career as a General Partner with Gateway Venture Associates. Prior to Gateway, Dr. Johnson served as Vice President of Monsanto Venture Capital Company. He sits on the boards of several private portfolio companies in the biomedical area and holds Ph.D. and M.A. in Physics from the University of Rochester. He graduated with a B.S. in Physics from the Massachusetts Institute of Technology.

Prior to joining NxThera in 2009, Bob was President, Chief Executive Officer, and a Director of Restore Medical, which was acquired by Medtronic in July 2008. Bob has held multiple finance and marketing leadership positions at Endocardial Solutions, Medtronic and General Mills. In addition to NxThera and Veran Medical, Bob serves as a Director of Sun Biopharma, Inc. and is a Director and Chairperson for several charitable foundations: Sister Kenny Foundation, Pillsbury Neighborhood Services and the Washburn Child Guidance Center. Bob received his J.D. from Vanderbilt University School of Law and holds an M.B.A. from the University of St. Thomas. He has a B.A. in Accounting, Economics & Political Science from Luther College.

Prior to Metavention, Inc., Kevin was President and Chief Executive Officer of Cameron Health, which was acquired by Boston Scientific in 2012. Before Cameron Health, Kevin was the Chief Commercial Officer of Visiogen, Inc., a venture-backed ophthalmology company acquired by Abbott Medical Optics in 2009. Kevin also had a 16-year career at Medtronic, where he held numerous leadership positions in the Cardiac Rhythm Management, Neurological, Heart Valve and Cardiac Surgery business units in the United States and Europe. In addition to Veran, Kevin also serves on the boards of Hansen Medical, Inc. and the Courage Kenny Rehabilitation Institute Foundation. Kevin has an M.B.A. from Northwestern University and graduated with a B.A. in Business Administration from the University of Wisconsin.

At Versant, Kirk has co-led investments in several medical companies such as Biotie (public), CardiAQ (sold), Cameron Health (sold), Lutonix (sold), Holaira, Inari Medical, Metavention, NeuWave Medical, Respicardia, Sequent Medical, Veran and Zyga Technology. Before Versant, Kirk held several commercial positions in Medtronic’s Cardiac Rhythm Management division and, before his business career, he was a professional hockey player. He obtained his M.B.A. from Harvard Business School, where he was a Baker Scholar, and graduated with a B.S. in Biology from Harvard College, where he received the John P. Reardon, Jr. Award as the college’s most outstanding scholar-athlete.

Learn more about the SPiN System™.

Contact us today